Avagen Pharma, Inc. focuses on cutting-edge technology and innovation to create disruptive products designed to improve healthcare for patients. After years of research and development with world-renowned scientists, Avagen has created the innovative solution to address Premature Ejaculation. Ristenza’s® patented formula is an innovative approach to potentially help with Premature Ejaculation (PE). Ristenza’s® therapeutic formula employs an “off-label use” of FDA-approved, multi-drug capsule that potentially provides highly effective relief for PE with none of the hassles associated with other currently available remedies. Ristenza’s® patented formula can be administered in dosages that permit the user to adjust the level of performance from minimal to complete control of their sexual experience.